<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Regeneron Awarded $450 Million to Manufacture REGN-COV2
Image Overlay - Regeneron Awarded $450 Million to Manufacture REGN-COV2

Regeneron Awarded $450 Million to Manufacture REGN-COV2

July 15, 2020

Regeneron Awarded $450 Million to Manufacture REGN-COV2

Regeneron was awarded a $450 million contract through the U.S. government-funded Operation Warp Speed to manufacture and supply REGN-COV2. The COVID-19 antibody cocktail is currently in two Phase 2/3 clinical trials. As a leader in warehouse and inventory management, Yourway can provide the full scope of all biopharmaceutical storage and distribution needs, maximizing efficiency, and decreasing risk on any candidate.

Back to Index
Media

Upcoming Events

Global Clinical Trial Innovation, Challenges, and Perspectives

June 6, 2024
Yourway's EU Flagship Depot in Dublin, Ireland

Precision in Pharma Supply Chain & Logistics Summit (San Diego)

October 21-22, 2024
San Diego

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?